Active, not recruitingNot applicableNCT06141018

Effectiveness and Safety of Intra-articular SEMICAL GEL-B CROSS Therapy in Knee Osteoarthritis (SEM-ART1)

Studying Microphthalmia with limb anomalies

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Semikal Technology
Principal Investigator
Aslıhan Kara
Semikal Technology
Intervention
Cross-linked intra-articular hyaluronic acid(device)
Enrollment
102 target
Eligibility
18 years · All sexes
Timeline
20252026

Study locations (1)

Collaborators

Antalya Training and Research Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06141018 on ClinicalTrials.gov

Other trials for Microphthalmia with limb anomalies

Additional recruiting or active studies for the same condition.

See all trials for Microphthalmia with limb anomalies

← Back to all trials